FEMALE HEALTH (Germany) Performance
| FMW Stock | EUR 0.68 0.02 2.86% |
The firm shows a Beta (market volatility) of 0.88, which means possible diversification benefits within a given portfolio. FEMALE HEALTH returns are very sensitive to returns on the market. As the market goes up or down, FEMALE HEALTH is expected to follow. At this point, FEMALE HEALTH has a negative expected return of -0.0268%. Please make sure to confirm FEMALE HEALTH's information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if FEMALE HEALTH performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days FEMALE HEALTH has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, FEMALE HEALTH is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 122.4 M | |
| Free Cash Flow | -48.2 M |
FEMALE |
FEMALE HEALTH Relative Risk vs. Return Landscape
If you would invest 73.00 in FEMALE HEALTH on August 31, 2024 and sell it today you would lose (5.00) from holding FEMALE HEALTH or give up 6.85% of portfolio value over 90 days. FEMALE HEALTH is producing return of less than zero assuming 4.1109% volatility of returns over the 90 days investment horizon. Simply put, 36% of all stocks have less volatile historical return distribution than FEMALE HEALTH, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
FEMALE HEALTH Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for FEMALE HEALTH's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as FEMALE HEALTH, and traders can use it to determine the average amount a FEMALE HEALTH's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0065
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FMW |
Estimated Market Risk
| 4.11 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average FEMALE HEALTH is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FEMALE HEALTH by adding FEMALE HEALTH to a well-diversified portfolio.
FEMALE HEALTH Fundamentals Growth
FEMALE Stock prices reflect investors' perceptions of the future prospects and financial health of FEMALE HEALTH, and FEMALE HEALTH fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on FEMALE Stock performance.
| Current Valuation | 350.37 M | |||
| Price To Book | 5.40 X | |||
| Price To Sales | 11.03 X | |||
| Revenue | 39.35 M | |||
| EBITDA | (78.96 M) | |||
| Total Debt | 9.66 M | |||
| Cash Flow From Operations | (47.51 M) | |||
| Total Asset | 136.13 M | |||
About FEMALE HEALTH Performance
By analyzing FEMALE HEALTH's fundamental ratios, stakeholders can gain valuable insights into FEMALE HEALTH's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if FEMALE HEALTH has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if FEMALE HEALTH has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about FEMALE HEALTH performance evaluation
Checking the ongoing alerts about FEMALE HEALTH for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for FEMALE HEALTH help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| FEMALE HEALTH generated a negative expected return over the last 90 days | |
| FEMALE HEALTH has some characteristics of a very speculative penny stock | |
| FEMALE HEALTH has high historical volatility and very poor performance | |
| The company reported the revenue of 39.35 M. Net Loss for the year was (83.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| FEMALE HEALTH generates negative cash flow from operations |
- Analyzing FEMALE HEALTH's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether FEMALE HEALTH's stock is overvalued or undervalued compared to its peers.
- Examining FEMALE HEALTH's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating FEMALE HEALTH's management team can have a significant impact on its success or failure. Reviewing the track record and experience of FEMALE HEALTH's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of FEMALE HEALTH's stock. These opinions can provide insight into FEMALE HEALTH's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for FEMALE Stock analysis
When running FEMALE HEALTH's price analysis, check to measure FEMALE HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FEMALE HEALTH is operating at the current time. Most of FEMALE HEALTH's value examination focuses on studying past and present price action to predict the probability of FEMALE HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FEMALE HEALTH's price. Additionally, you may evaluate how the addition of FEMALE HEALTH to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |